Brief: Virpax Pharmaceuticals Inc On March 15, Got Letter From Nasdaq That Co Has Regained Compliance With Listing Rule 5550(A)(2)
March 18 (Reuters) - Virpax Pharmaceuticals Inc
VRPX.O :
* VIRPAX PHARMACEUTICALS INC: ON MARCH 15, GOT LETTER FROM
NASDAQ
THAT CO HAS REGAINED COMPLIANCE WITH LISTING RULE 5550(A)(2)
Source text for Eikon: ID:n0001213900-24-023188
Further company coverage: VRPX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Virpax Pharmaceuticals
See all newsVirpax Pharma plunges as Nasdaq delisting looms
Brief: Virpax Pharmaceuticals Files For Offering On Best Efforts Basis Up To 2.4 Million Shares Of Common Stock
Brief: Virpax receives positive Probudur™ results for dose range study
Brief: Virpax Looking To Use Met To Develop Intranasal Covid Vaccine
Brief: Virpax Confirms Positive Results With Us Army With Probudur™ For Combat Care Study